Your Global 5F Biologics CDMO from Preclinical to Commercial

Focused-on-Patients |  Friendly |  Flexible |  Fast |  Future-driven

ABOUT BIODEXTRIS

Built on GSK’s legacy and powered by a state-of-the-art GMP facility, Biodextris is a global biologics CDMO committed to supporting innovators from early development to commercial manufacturing." 

We provide end-to-end services — including analytical development, process development, QC testing and GMP biomanufacturing — with the agility and expertise needed to bring life-changing therapies to patients worldwide.

See Company Profile

OUR SERVICES

PROCESS
DEVELOPMENT

Development of upstream production, downstream

purification and bulk production capability for microbial, mammalian and insect cells.

Explore process development services

GMP
BIOMANUFACTURING

High-quality protein production specialization, with a high-focus on regulatory compliance,

scalability and product
excellence.

6,500 sq. ft. (600m²) of
GMP compliant BSL2
cleanroo
ms

5-200L bioreactors

From development to GMP Phase III, with the ability to scale as your program advances

Small scale aseptic Fill &
Finish for vials and PFS

Explore biomanufacturing services

ANALYTICAL
DEVELOPMENT &
QUALITY CONTROL

Development of complete analytical packages and GMP compliant bio analytical
testing enabling Quality Control.

Fully equipped bioanalytical lab

In-house ICH Stability
Storage and Testing

Robust Quality Management System

Explore analytical & QC services

OUR FACILITY

Our 32,000 sq. ft. (3,000 m²) state-of-the-art facility is designed to drive innovation, collaboration, and growth at every stage of development.

Discover our state of the art facility

TESTIMONIALS

What Our Clients Say About Us

“Our vaccine product requires a new recombinant protein processing step that has never before been used in clinical manufacturing of biological products. As such, we have hard technical difficulties in manufacturing product development. However, partnership with Biodextris has produced a drug substance significantly more effective than all the materials tested to date — 17x higher neutralizing antibody response than the current market leading recombinant RSV vaccine!”

— Chris Marshall, CEO of Calder Biosciences

“Every client that we have referred to Biodextris has had nothing but positive feed-back, which has not always been the case when we’ve referred other CDMO partners”

— Business Development Officer, National Research
Council Canada

“We are very happy with the purity Biodextris was able to achieve compared to all the CDMOs we’ve worked with! Virtually 100% of the VLPs are mature: we are thrilled by the results their expertise delivered - science prevails!”

— Associate Director Analytical Development, Top 20
Global Pharma

GET IN TOUCH WITH OUR FRIENDLY TEAM

We welcome you to contact us with any inquiry — we will answer you shortly!

Contact - Contact Us